Clinical Trial Update: A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)

View source ↗

Summary

This clinical trial evaluated golimumab (Simponi) in adults with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. The study is completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Psoriatic Arthritis
• Rheumatoid Arthritis

Drugs mentioned

• Simponi (golimumab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Arthritis, Rheumatoid, Arthritis, Psoriatic | Status: COMPLETED | Results posted: 2016-11-01